首頁 > 市場調查報告書 > 製藥

生技設備生物工藝

市場調查報告書

商品編碼

1375201

北美生物製程技術市場預測至 2028 年 - 按類型、模式和最終用戶進行的區域分析

North America Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type, Modality, and End User

出版日期: 2023年09月14日 | 出版商:

The Insight Partners | 英文 129 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美生物製程技術市場預計將從2023年的158.6906億美元成長到2028年的336.9606億美元。預計2023年至2028年年複合成長率為16.3%。

慢性病盛行率不斷上升推動北美生物製程技術市場

空前的人口老化速度和長期缺乏身體活動正在加劇肥胖和糖尿病等生活方式障礙的盛行率。基因可導致心血管疾病 (CVD)、糖尿病、肥胖、阿茲海默症和憂鬱症等疾病。據國家老化委員會稱，80% 的成年人（65 歲及以上）一生中至少患有一種慢性病，而 68% 的人患有兩種或兩種以上。根據美國疾病管制與預防中心(CDC) 的數據，2020 年，美國每10 人中就有近6 人患有至少一種嚴重疾病，每10 人中就有4 人患有兩種或兩種以上慢性病。心血管疾病，如心絞痛忙碌的生活方式引起的動脈粥狀硬化和急性心肌梗塞是該地區死亡的重要原因。糖尿病是一種危及生命的慢性疾病，無法進行功能性治癒。所有類型的糖尿病都會在不同的身體部位引起各種併發症，增加整體死亡風險。心臟病、腎衰竭、中風、截肢、神經損傷和視力喪失是與糖尿病相關的主要併發症。根據國際糖尿病聯盟（IDF）預測，北美糖尿病病例預計將從2017年的4,600萬增加到2045年的6,200萬人。資料進一步顯示，2017年有4.25億人患有糖尿病，這一數字很可能達到2045年，全球人口將達6.29 億。在預測期內，該疾病的盛行率可能會增加約 35%。患者、專家、初級保健臨床醫生和其他醫療保健專業人員認知到生物相似藥是有效且安全的藥物，這正在推動其需求。生物相似藥已被證明可以改善數百萬患者的生活品質。它們是治療許多疾病的有效且經濟有效的選擇，包括慢性皮膚病（如牛皮癬、異位性皮膚炎）、腸道疾病（如克隆氏症、腸躁症和結腸炎）、糖尿病、自身免疫性疾病、癌症、腎臟病條件和關節炎。生物相似藥開發商正在採用先進的生物加工技術來降低製造成本，這是決定最終消費者價格的重要因素。幾乎所有生物相似藥開發商都在使用現代的、通常是尖端的生物加工技術。這表明大多數生物相似藥是使用一次性（使用後處置）生物加工系統開發的。隨著慢性病的日益流行，對治療危及生命的疾病的生物相似藥的需求不斷增加，從而推動了對生物加工技術的需求。

北美生物製程技術市場概況

根據美國食品藥物管理局 (FDA) 的報告，美國有超過 3,000 萬人患有約 7,000 種罕見疾病，這些疾病危及生命，但治療選擇卻很少。由於缺乏對罕見疾病歷史的了解以及臨床試驗的困難，治療罕見疾病的藥物、生物和設備開發具有挑戰性。因此，基因和細胞療法（CGT）以及特種藥物等生物製程技術的發展代表了罕見疾病治療的根本轉變。例如，與治療罕見疾病的配方藥物相比，CGT 具有顯著的健康益處。在美國，超過 900 項針對基因治療產品的研究性新藥 (IND) 申請正在進行中。此外，FDA 每年批准 10-20 種基因療法。同樣，2022 年 8 月，FDA 批准了 Bluebird Bio 的「Zynteglo (betibeglogene autotemcel)」。這是美國批准的最昂貴的單次申請藥物，用於治療一種罕見的神經系統疾病—腦性腎上腺腦白質營養不良（CALD）。

北美生物製程技術市場收入及 2028 年預測（百萬美元）

北美生物製程技術市場細分

北美生物製程技術市場按類型、模式、最終用戶和國家進行細分。

根據類型，北美生物製程技術市場分為細胞培養基生物製程、色譜生物製程以及消耗品和配件等。 2023年，細胞培養基生物製程領域在北美生物製程技術市場中佔據最大佔有率。

根據模式，北美生物加工技術市場分為一次性使用和多次使用。 2023 年，一次性細分市場在北美生物製程技術市場中佔據更大佔有率。

根據最終用途，北美生物製程技術市場分為學術和醫療機構、生物製藥公司、研究實驗室等。 2023年，生物製藥公司細分市場在北美生物製程技術市場中佔據最大佔有率。

根據國家/地區，北美生物程序技術市場分為美國、加拿大和墨西哥。 2023年，美國市場在北美生物製程技術市場中佔據最大佔有率。

康寧公司；丹納赫公司；艾本德公司；龍沙集團股份公司；默克公司；雷普利根公司；賽多利斯公司；斯塔姆生物技術公司；和 Thermo Fisher Scientific Inc 是北美生物製程技術市場上的一些領先公司。

The unprecedented rate of aging population and extended periods of physical inactivity are boosting the prevalence lifestyle disorders, such as obesity and diabetes. Genes can cause conditions such as cardiovascular disease (CVDs), diabetes, obesity, Alzheimer's disease, and depression. According to the National Council on Aging, Inc., 80% of adults (aged 65 and more) are reported to suffer from at least one chronic condition in their lifetime, while 68% have two or more. According to the Centers for Disease Control and Prevention (CDC), nearly 6 of 10 people in the US suffered from at least one serious disease, and 4 of 10 people have had two or more chronic conditions in 2020. CVDs, such as angina pectoris, atherosclerosis, and acute myocardial infarction, caused due to hectic lifestyles are significant causes of mortality across the region. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes of all types can cause various complications in different body parts, thereby increasing the overall risk of death. Heart attack, kidney failure, stroke, leg amputation, nerve damage, and vision loss are among the major complications associated with diabetes. According to the International Diabetes Federation (IDF), diabetic cases in North America are expected to reach 62 million by 2045 from 46 million in 2017. The data further reported that 425 million people suffered from diabetes in 2017, and the count is likely to reach 629 million by 2045 worldwide. The disease prevalence is likely to increase by about 35% during the forecast period. Recognition of biosimilars as efficacious and safe agents by patients, specialists, primary care clinicians, and other healthcare professionals is propelling its demand. Biosimilars have proven to improve the quality of life for millions of patients. They are effective and cost-effective options in treating many diseases, including chronic skin conditions (such as psoriasis, Atopic Dermatitis), bowel diseases (such as Crohn's disease, irritable bowel syndrome, and colitis), diabetes, autoimmune disease, cancer, kidney conditions, and arthritis. Biosimilar developers are adopting advanced bioprocessing technologies to achieve lower manufacturing costs, an important factor determining final consumer prices. Nearly all biosimilar developers are using modern, often cutting-edge bioprocessing techniques. This indicates that a majority of biosimilars are being developed using single use (disposed of after-use) bioprocessing systems. With the growing prevalence of chronic diseases, the demand for biosimilars to treat life-threatening illnesses is spurring, thereby propelling the demand for bioprocessing technologies.

North America Bioprocess Technology Market Overview

According to the Food and Drug Administration (FDA) report, over 30 million people in the US suffer from ~7,000 rare diseases, accounting for life-threatening conditions with low treatment options. Drug, biological, and device development in the treatment of rare diseases is challenging due to a lack of understanding of the history of rare diseases and difficulty in conducting clinical trials. Therefore, the growth of bioprocess technologies such as gene and cell therapies (CGTs) and specialty pharmaceuticals represent a radical shift in the treatment of rare diseases. For example, CGTs have revealed significant health benefits than formulated drugs for treating rare diseases. In the US, more than 900 investigational new drug (IND) applications targeting gene therapy products are underway. Also, 10-20 gene therapies are approved annually by the FDA. Likewise, in August 2022, the FDA approved Bluebird Bio's "Zynteglo (betibeglogene autotemcel)." It was the most expensive single-application drug approval in the US intended for the treatment of a rare neurological disorder-cerebral adrenoleukodystrophy (CALD).

North America Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)

North America Bioprocess Technology Market Segmentation

The North America bioprocess technology market is segmented into type, modality, end user, and country.

Based on type, the North America bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, and consumables & accessories, and others. In 2023, the cell culture media bioprocess segment registered a largest share in the North America bioprocess technology market.

Based on modality, the North America bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the North America bioprocess technology market.

Based on end-use, the North America bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered a largest share in the North America bioprocess technology market.

Based on country, the North America bioprocess technology market is segmented into the US, Canada, and Mexico. In 2023, the US segment registered a largest share in the North America bioprocess technology market.

Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; STAMM Biotech; and Thermo Fisher Scientific Inc are some of the leading companies operating in the North America bioprocess technology market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America bioprocess technology market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the bioprocess technology market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Bioprocess Technology Market - by Type
- 1.3.2 North America Bioprocess Technology Market - by Modality
- 1.3.3 North America Bioprocess Technology Market - by End User
- 1.3.1 North America Bioprocess Technology Market - by Country

2. North America Bioprocess Technology Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Bioprocess Technology Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Expert's Opinion

5. North America Bioprocess Technology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
- 5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies
5.3 Market Opportunities
- 5.3.1 Introducing Advanced Bioprocess Technologies
5.4 Future Trends
- 5.4.1 Emergence of Automated Real-Time Flow Cytometry (ART-FCM)
5.5 Impact Analysis

6. Bioprocess Technology Market - North America Analysis

6.1 North America Bioprocess Technology Market Revenue Forecast and Analysis

7. North America Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

7.1 Overview
7.2 North America Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
7.3 Cell Culture Media Bioprocess
- 7.3.1 Overview
- 7.3.2 Cell Culture Media Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Chromatography Bioprocess
- 7.4.1 Overview
- 7.4.2 Chromatography Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Consumables & Accessories
- 7.5.1 Overview
- 7.5.2 Consumables & Accessories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

8.1 Overview
8.2 North America Bioprocess Technology Market, by Modality 2022 & 2028 (%)
8.3 Single Use
- 8.3.1 Overview
- 8.3.2 Single Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Multiple Use
- 8.4.1 Overview
- 8.4.2 Multiple Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

9.1 Overview
9.2 North America Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
9.3 Academic & Medical Institutions
- 9.3.1 Overview
- 9.3.2 Academic & Medical Institutions: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Biopharmaceutical Companies
- 9.4.1 Overview
- 9.4.2 Biopharmaceutical Companies: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Research Laboratories
- 9.5.1 Overview
- 9.5.2 Research Laboratories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Bioprocess Technology Market - Revenue and Forecast to 2028 - Country Analysis

10.1 North America: Bioprocess Technology Market
- 10.1.1 Overview
- 10.1.2 North America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
  - 10.1.2.1 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 US: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.1.4 US: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.2.1.5 US: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.2.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 Canada: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.2.4 Canada: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.2.2.5 Canada: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.2.3 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 Mexico: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.3.4 Mexico: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.2.3.5 Mexico: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. North America Bioprocess Technology Market - Industry Landscape

11.1 Overview
11.2 Organic Growth Strategies
- 11.2.1 Overview
11.3 Inorganic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Merck KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sartorius AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Corning Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 STAMM Biotech
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Lonza Group AG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Eppendorf SE
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Repligen Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Danaher Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
Table 2. US Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Recent Organic Growth Strategies in Bioprocess Technology Market
Table 12. Recent Inorganic Growth Strategies in the North America bioprocess technology market
Table 13. Glossary of Terms

List Of Figures

Figure 1. North America Bioprocess Technology Market Segmentation
Figure 2. North America Bioprocess Technology Market, by Country
Figure 3. North America Bioprocess Technology Market Overview
Figure 4. Cell Culture Media Bioprocess Segment Held Largest Share of Type Segment in North America Bioprocess Technology Market
Figure 5. Canada Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. North America Bioprocess Technology Market Impact and Analysis
Figure 9. North America Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. North America Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
Figure 11. Cell Culture Media Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Chromatographic Bioprocess: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Consumables & Accessories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Bioprocess Technology Market, by Modality 2022 & 2028 (%)
Figure 16. Single Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Use: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
Figure 19. Academic & Medical Institutions: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Biopharmaceutical Companies: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Research Laboratories: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)